The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Down-Regulation of Akt/Mammalian Target of Rapamycin Signaling Pathway in Response to Myostatin Overexpression in Skeletal Muscle
Abstract
Myostatin, a member of the TGF-β family, has been identified as a master regulator of embryonic myogenesis and early postnatal skeletal muscle growth. However, cumulative evidence also suggests that alterations in skeletal muscle mass are associated with dysregulation in myostatin expression and that myostatin may contribute to muscle mass loss in adulthood. Two major branches of the Akt pathway are relevant for the regulation of skeletal muscle mass, the Akt/mammalian target of rapamycin (mTOR) pathway, which controls protein synthesis, and the Akt/forkhead box O (FOXO) pathway, which controls protein degradation. Here, we provide further insights into the mechanisms by which myostatin regulates skeletal muscle mass by showing that myostatin negatively regulates Akt/mTOR signaling pathway. Electrotransfer of a myostatin expression vector into the tibialis anterior muscle of Sprague Dawley male rats increased myostatin protein level and decreased skeletal muscle mass 7 d after gene electrotransfer. Using RT-PCR and immunoblot analyses, we showed that myostatin overexpression was ineffective to alter the ubiquitin-proteasome pathway. By contrast, myostatin acted as a negative regulator of Akt/mTOR pathway. This was supported by data showing that the phosphorylation of Akt on Thr308, tuberous sclerosis complex 2 on Thr1462, ribosomal protein S6 on Ser235/236, and 4E-BP1 on Thr37/46 was attenuated 7 d after myostatin gene electrotransfer. The data support the conclusion that Akt/mTOR signaling is a key target that accounts for myostatin function during muscle atrophy, uncovering a novel role for myostatin in protein metabolism and more specifically in the regulation of translation in skeletal muscle. Myostatin down-regulates Akt/mammalian target of rapamycin (mTOR) signaling pathway uncovering a novel role for myostatin in protein metabolism and more specifically in the regulation of translation in skeletal muscle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
What is the cause of the ageing atrophy?
Lexell, J., Taylor, C. C., & Sjöström, M. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90132-3 · Cited by 2,075
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
FoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539
Zhao, J., Brault, J. J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.004 · Cited by 1,489
Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J., & Sabatini, D. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.007 · Cited by 1,415
Mutations in myostatin ( GDF8 ) in Double-Muscled Belgian Blue and Piedmontese Cattle
Kambadur, R., Sharma, M., Smith, T. P. L., & Bass, J. J. (1997) · Genome Research · doi:10.1101/gr.7.9.910 · Cited by 1,204
The Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008
Signaling in Muscle Atrophy and Hypertrophy
Sandri, M. (2008) · Physiology · doi:10.1152/physiol.00041.2007 · Cited by 827
Myostatin negatively regulates satellite cell activation and self-renewal
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., & Kambadur, R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207056 · Cited by 784
The mTOR pathway in the control of protein synthesis
Wang, X., & Proud, C. G. (2006) · Physiology · doi:10.1152/physiol.00024.2006 · Cited by 778
DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D., & Ellisen, L. W. (2008) · Genes & Development · doi:10.1101/gad.1617608 · Cited by 710 · cited 1×
“Finally, the protein level of regulated in development and DNA damage response 1, a negative regulator of mTOR (43), was not modified in response to myostatin overexpression (data not shown).”
Sekulić, A., Hudson, C. C., Homme, J. L., Yin, P., Otterness, D. M., Karnitz, L. M., & Abraham, R. T. (2000) · PubMed · Cited by 710
Gonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571
McFarlane, C., Plummer, E., Thomas, M., Hennebry, A., Ashby, M., Ling, N., Smith, H., Sharma, M., & Kambadur, R. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20757 · Cited by 480
Tsujinaka, T., Fujita, J., Ebisui, C., Yano, M., Kominami, E., Suzuki, K., Tanaka, K., Katsume, A., Ohsugi, Y., Shiozaki, H., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118398 · Cited by 421
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells
Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H., Kull, F. C., & Gonzalez-Cadavid, N. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e221 · Cited by 410
Intracellular signaling during skeletal muscle atrophy
Kandarian, S. C., & Jackman, R. W. (2006) · Muscle & Nerve · doi:10.1002/mus.20442 · Cited by 393
Peterson, R. T., Beal, P. A., Comb, M. J., & Schreiber, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7416 · Cited by 339
Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin
Joulia, D., Bernardi, H., Garandel, V., Rabenoelina, F., Vernus, B., & Cabello, G. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00074-0 · Cited by 337
Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin
Reisz-Porszasz, S., Bhasin, S., Artaza, J. N., Shen, R., Sinha-Hikim, I., Hogue, A., Fielder, T. J., & Gonzalez-Cadavid, N. F. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00107.2003 · Cited by 333
Cheng, S. W. Y., Fryer, L. G. D., Carling, D., & Shepherd, P. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300534200 · Cited by 331
Myostatin is an inhibitor of myogenic differentiation
Rı́os, R., Carneiro, I., Arce, V. M., & Devesa, J. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00372.2001 · Cited by 323
Peinnequin, A., Mouret, C., Birot, O., Alonso, A., Mathieu, J., Clarençon, D., Agay, D., Chancerelle, Y., & Multon, E. (2004) · BMC Immunology · doi:10.1186/1471-2172-5-3 · Cited by 315
Self-citationYarasheski, K. E., Bhasin, S., Sinha‐Hikim, I., Pak-Loduca, J., & González-Cadavid, N. F. (2002) · PubMed · Cited by 293
Baghdiguian, S., Martin, M., Richard, I., Pons, F., Astier, C., Bourg, N., Hay, R. T., Chemaly, R., Halaby, G., Loiselet, J., et al. (1999) · Nature Medicine · doi:10.1038/8385 · Cited by 278
Myostatin Gene Deletion Prevents Glucocorticoid-Induced Muscle Atrophy
Gilson, H., Schakman, O., Combaret, L., Lause, P., Grobet, L., Attaix, D., Ketelslegers, J. M., & Thissen, J. P. (2007) · Endocrinology · doi:10.1210/en.2006-0539 · Cited by 278
Muscle Cachexia: Current Concepts of Intracellular Mechanisms and Molecular Regulation
Hasselgren, P.-O., & Fischer, J. E. (2001) · Annals of Surgery · doi:10.1097/00000658-200101000-00003 · Cited by 277
Reardon, K. A., Davis, J., Kapsa, R. M. I., Choong, P., & Byrne, E. (2001) · Muscle & Nerve · doi:10.1002/mus.1086 · Cited by 227
Féasson, L., Stockholm, D., Freyssenet, D., Richard, I., Duguez, S., Beckmann, J. S., & Denis, C. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.018689 · Cited by 224
Self-citationIncreased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats.
Temparis, S., Asensi, M., Taillandier, D., AUROUSSEAU, E., Larbaud, D., Obled, A., Béchet, D., Ferrara, M., Estrela, J. M., & Attaix, D. (1994) · PubMed · Cited by 214
Myostatin Regulates Cell Survival during C2C12 Myogenesis
Ríos, R., Carneiro, I., Arce, V. M., & Devesa, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4159 · Cited by 189
Mitochondrial biogenesis during skeletal muscle regeneration
Duguez, S., Féasson, L., Denis, C., & Freyssenet, D. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00343.2001 · Cited by 183
Self-citationTherapeutic approaches for muscle wasting disorders
Lynch, G. S., Schertzer, J. D., & Ryall, J. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.004 · Cited by 169
Cellular and molecular events controlling skeletal muscle mass in response to altered use
Favier, F. B., Benoit, H., & Freyssenet, D. G. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0423-z · Cited by 169
Self-citationDurieux, A.-C., Amirouche, A., Banzet, S., Koulmann, N., Bonnefoy, R., Pasdeloup, M., Mouret, C., Bigard, X., Peinnequin, A., & Freyssenet, D. (2007) · Endocrinology · doi:10.1210/en.2006-1500 · Cited by 161
Self-citationKramerova, I. A., Kudryashova, E., Venkatraman, G., & Spencer, M. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi217 · Cited by 153
A novel ubiquitin‐binding protein ZNF216 functioning in muscle atrophy
Hishiya, A., Iemura, S., Natsume, T., Takayama, S.-I. J., Ikeda, K., & Watanabe, K. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600945 · Cited by 144
Du, J., Mitch, W. E., Wang, X., & Price, S. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907258199 · Cited by 135
Regulation of skeletal-muscle–protein turnover in cancer-associated cachexia
Baracos, V. E. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00407-x · Cited by 127
Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass
Magee, T. R., Artaza, J. N., Ferrini, M. G., Vernet, D., Zuniga, F. I., Cantini, L. P., Reisz‐Porszasz, S., Rajfer, J., & González-Cadavid, N. F. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.946 · Cited by 118
The role of ubiquitin–proteasome-dependent proteolysis in the remodelling of skeletal muscle
Taillandier, D., Combaret, L., Pouch-Pélissier, M.-N., Samuels, S., Béchet, D., & Attaix, D. (2004) · Proceedings of The Nutrition Society · doi:10.1079/par2004358 · Cited by 91
Koncarevic, A., Jackman, R. W., & Kandarian, S. C. (2007) · The FASEB Journal · doi:10.1096/fj.06-6665com · Cited by 90
Bartoli, M., Poupiot, J., Vulin, A., Fougerousse, F., Arandel, L., Danièle, N., Roudaut, C., Noulet, F., García, L., Danos, O., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302928 · Cited by 89
Durieux, A., Bonnefoy, R., Busso, T., & Freyssenet, D. G. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.534 · Cited by 85
Self-citationMyostatin inhibits rhabdomyosarcoma cell proliferation through an Rb-independent pathway
Langley, B. C., Thomas, M., McFarlane, C., Gilmour, S., Sharma, M., & Kambadur, R. (2004) · Oncogene · doi:10.1038/sj.onc.1207144 · Cited by 69
Identification and Characterization of Differentially Expressed Genes in Denervated Muscle
Tang, H., Cheung, W. M. W., Ip, F. C. F., & Ip, N. Y. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0864 · Cited by 68
Duguez, S., Bihan, M. L., Gouttefangeas, D., Féasson, L., & Freyssenet, D. G. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00331.2002 · Cited by 66
Self-citationExpression of three calpain isoform genes in human skeletal muscles
Ueyama, H., Kumamoto, T., Fujimoto, S., Murakami, T., & Tsuda, T. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00309-2 · Cited by 46
Berthon, P. M., Duguez, S., Favier, F. B., Amirouche, A., Féasson, L., Vico, L., Denis, C., & Freyssenet, D. G. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0230-6 · Cited by 41
Self-citationDurieux, A., Bonnefoy, R., Manissolle, C., & Freyssenet, D. G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00901-4 · Cited by 41
Self-citationCalpain-3 gene expression is decreased during experimental cancer cachexia
Busquets, S., Garcia‐Martínez, C., Alvarez, B., Carbó, N., López-Soriano, F. J., & Argilés, J. M. A. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00050-7 · Cited by 38
Cited by
Cellular and molecular mechanisms of muscle atrophy
Bonaldo, P., & Sandri, M. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010389 · Cited by 1,284
Exercise is the real polypill.
Fiuza-Luces, C., Garatachea, N., Berger, N. A., & Lucia, A. (2013) · Physiology · doi:10.1152/physiol.00019.2013 · Cited by 791
Glucocorticoid-Induced Skeletal Muscle Atrophy
Schakman, O., Kalista, S., Barbé, C., Loumaye, A., & Thissen, J. P. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.036 · Cited by 705
Furrer, R., Jaspers, R. T., Baggerman, H. L., Bravenboer, N., Lips, P., & de Haan, A. (2013) · BioMed Research International · doi:10.1155/2013/935671 · Cited by 531
mTOR as a key regulator in maintaining skeletal muscle mass
Yoon, M.-S. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00788 · Cited by 495
Metadata
- Authors
- Amirouche, A., Durieux, A.-C., Banzet, S., Koulmann, N., Bonnefoy, R., Mouret, C., Bigard, X., Peinnequin, A., & Freyssenet, D.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2008-09-18
- Volume
- 150
- Issue
- 1
- Pages
- 286-294
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2116769367
- Cited by
- 282
- References
- 61
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.